Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer

por Jimenez, Camilo
Publicado 2018

Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors

por Toledo, Rodrigo, Jimenez, Camilo
Publicado 2018

SAT-229 Bilateral Pheochromocytoma as Incidental Finding in a Patient with Neurofibromatosis Type 1

por Herrera, Raul A, Jimenez, Camilo
Publicado 2020

Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies

por Gómez, Karen, Varghese, Jeena, Jiménez, Camilo
Publicado 2011

Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidi...

por Jimenez, Camilo, Erwin, William, Chasen, Beth
Publicado 2019

SUN-348 Cabozantinib in Advanced Adrenocortical Carcinoma: Rationale and Protocol of Two Phase II Clinical Trials

por Kroiss, Matthias, Goebeler, Maria-Elisabeth, Jimenez, Camilo, Malzahn, Uwe, Fassnacht, Martin, Habra, Mouhammed
Publicado 2019

A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature

por Economides, Minas P., Shah, Amishi Y., Jimenez, Camilo, Habra, Mouhammed A., Desai, Monica, Campbell, Matthew T.
Publicado 2020

Mitotane-Induced Hyperlipidemia: A Retrospective Cohort Study

por Shawa, Hassan, Deniz, Ferhat, Bazerbashi, Hadil, Hernandez, Mike, Vassilopoulou-Sellin, Rena, Jimenez, Camilo, Habra, Mouhammed Amir
Publicado 2013

Ectopic Cushing syndrome in Colombia

por Lopez-Montoya, Vanessa, Gutierrez-Restrepo, Johnayro, Grajales, Jose Luis Torres, Aristizabal, Natalia, Pantoja, Doly, Roman-Gonzalez, Alejandro, Jimenez, Camilo
Publicado 2020

Malignant head and neck paragangliomas: Is there an optimal treatment strategy?

por Moskovic, Daniel J, Smolarz, Joseph R, Stanley, Douglas, Jimenez, Camilo, Williams, Michelle D, Hanna, Ehab Y, Kupferman, Michael E
Publicado 2010

Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?

por Jimenez, Camilo, Armaiz-Pena, Gustavo, Dahia, Patricia L. M., Lu, Yang, Toledo, Rodrigo A., Varghese, Jeena, Habra, Mouhammed Amir
Publicado 2022

Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K/Akt/mTOR signaling pathway

por Arias-Calderón, Manuel, Casas, Mariana, Balanta-Melo, Julián, Morales-Jiménez, Camilo, Hernández, Nadia, Llanos, Paola, Jaimovich, Enrique, Buvinic, Sonja
Publicado 2023

Mechanical Disturbance of Osteoclasts Induces ATP Release That Leads to Protein Synthesis in Skeletal Muscle through an Akt-mTOR Signaling Pathway

por Morales-Jiménez, Camilo, Balanta-Melo, Julián, Arias-Calderón, Manuel, Hernández, Nadia, Gómez-Valenzuela, Fernán, Escobar, Alejandro, Jaimovich, Enrique, Buvinic, Sonja
Publicado 2022

Review of Immune-Related Adverse Events in Prostate Cancer Patients Treated with Ipilimumab: MD Anderson Experience

por Gao, Jianjun, He, Qiuming, Subudhi, Sumit, Aparicio, Ana, Zurita-Saavedra, Amado, Lee, Da Hyun, Jimenez, Camilo, Suarez-Almazor, Maria, Sharma, Padmanee
Publicado 2015

Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma

por Jimenez, Camilo, Chin, Bennett B, Noto, Richard B, Dillon, Joseph S, Solnes, Lilja, Stambler, Nancy, DiPippo, Vincent A, Pryma, Daniel A
Publicado 2022

SAT-175 Trial in Progress Interim Report: A Phase II Clinical Trial Using Single Agent Cabozantinib in Advanced Adrenocortical Carcinoma

por Bedrose, Sara Shokry Daniel, Altameemi, Lina, Daher, Marilyne, De Rosa, Gina Tamsen, Varghese, Jeena Mary, Jimenez, Camilo, Campbell, Matthew, Habra, Mouhammed Amir
Publicado 2020

Biochemical Tumor Marker Status and Its Role in Treatment Response in Patients Who Received High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL):...

por Jimenez, Camilo, Chin, Bennett B, Noto, Richard A, Noto, Richard B, Dillon, Joseph S, Solnes, Lilja, DiPippo, Vincent A, Stambler, Nancy, Pryma, Daniel A
Publicado 2021

OR25-07 A Multi-Center, Open-Label, Pivotal Phase 2 Study of Azedra® (HSA I-131-MIBG) in Patients with Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paragangliom...

por Jimenez, Camilo, Chin, Bennett B, Noto, Richard B, Dillon, Joseph Stephen, Solnes, Lilja B, DiPippo, Vincent A, Stambler, Nancy, Wong, Vivien, Pryma, Daniel A
Publicado 2020

Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas

por Jimenez, Camilo, Subbiah, Vivek, Stephen, Bettzy, Ma, Junsheng, Milton, Denai, Xu, Mingxuan, Zarifa, Abdualrazzak, Akhmedzhanov, Fechukwu Omolara, Tsimberidou, Apostolia, Habra, Mouhammed Amir, Rodon Anhert, Jordi, Fu, Siqing, Naing, Aung
Publicado 2020

FRI191 Changes In The Incidence And Geographical Distribution Of Adrenocortical Carcinoma: A Retrospective Analysis Of A State Cancer Registry

por Brondani, Vania B, Griffin, Allison M, Owen, Taylor J, Merriman, Kelly W, Varghese, Jeena M, Jimenez, Camilo, Waguespack, Steven G, Graham, Paul H, Campbell, Matthew T, Hassan, Manal M, Habra, Mouhammed A
Publicado 2023